We previously reported that in mice with reduced plasma IGF-I levels from birth [20] or decreased IGF-I bioavailability [21], the incidence of experimental colon carcinoma liver metastases was markedly reduced and this coincided with an altered inflammatory response to the invading tumor cells and increased tumor cell apoptosis, respectively. This evidence concerns the gene IGF1 and colon carcinoma.